ArticleRMD open2021

Assessment of impact of the COVID-19 pandemic from the perspective of patients with rheumatic and musculoskeletal diseases in Europe: results from the REUMAVID study (phase 1).

Marco Garrido-Cumbrera et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.